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Abstract
Objective: To determine if adiposity in later life increases dementia hazard.
Methods: Cohort study of 12,047 men aged 65–84 years living in Perth, Australia. Adiposity exposures were baseline body
mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR). We used the Western Australian Data Linkage
System (WADLS) to establish the presence of new cases of dementia between 1996 and 2009 according to the International
Classification of Diseases (ICD). Crude and adjusted hazard ratio (HR, 95% confidence interval, 95%CI) of dementia for each
adiposity marker was calculated using Cox regression models. Other measured factors included age, marital status,
education, alcohol use, smoking, diet, physical activity, and prevalent hypertension, diabetes, dyslipidaemia and
cardiovascular disease.
Results: Compared with men with BMI,25, participants with BMI between 25–30 had lower adjusted HR of dementia
(HR=0.82, 95% CI=0.70–0.95). The HR of dementia for men with BMI$30 was comparable to men with BMI,25 (HR=0.82,
95%CI=0.67–1.01). Waist circumference showed no obvious association with dementia hazard. Men with WHR$0.9 had
lower adjusted HR of dementia than men with WHR ,0.9 (HR=0.82, 95%CI=0.69–0.98). We found a ‘‘J’’ shape association
between measures of obesity and the hazard of dementia, with the nadir of risk being in the overweight range of BMI and
about 1 for WHR.
Conclusions: Higher adiposity is not associated with incident dementia in this Australian cohort of older men. Overweight
men and those with WHR$0.9 have lower hazard of dementia than men with normal weight and with WHR,0.9.
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Introduction
The prevalence of obesity in older Australians has tripled
between 1985 and 2004, affecting 22% of men aged 65–74 and
14% of those older than 75 years [1]. However, there is
controversy over whether obesity guidelines that have been
developed for adults should be applied to the elderly [2], as
mortality risk seems lowest for overweight older people [3].
Likewise, the association between measures of obesity and
dementia risk remains debatable. Surveys investigating adiposity
in mid- life indicate that being overweight or obese increases
dementia risk later in life [4,5,6,7,8,9,10], although not all
longitudinal data are supportive of such an association [11].
Observational studies examining the link between adiposity in
later life and dementia risk have produced less consistent results.
For example, in a 18-year prospective study in Sweden, higher
body mass index (BMI) between ages 70 to 79 years increased the
risk of dementia only in women aged 79–88 years [12]. In
contrast, recent investigations found that older people who are
overweight or obese may actually have lower risk of developing
dementia than those who have normal weight [9,13,14], although
confounding and healthy survivorship bias may explain these
inconsistent and disparate findings.
The varying measures used to guide the definition of obesity
represent another complicating factor when comparing studies of
incident dementia, as some use BMI whilst others emphasize the
importance of central obesity as determined by the waist
circumference (WC) or waist-to-hip ratio (WHR).
We designed the present study to determine if BMI and
measures of central adiposity are associated with incident
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17902dementia in a community-dwelling sample of older men, once
demographic, lifestyle and medical morbidities are taken into
account. As we used record linkage, loss to follow-up due to
differential survival was negligible.
Methods
Study Design
Cohort study of men aged 65–84 years at the time of
enrollment.
Setting
We recruited community-dwelling men living in the Perth
metropolitan area, Western Australia.
Participants
The Health In Men Study (HIMS) used a copy of the electoral
roll to recruit participants in 1996 (voting is compulsory in
Australia) [15]. Eligible men were aged between 65–84 and
resident in Perth at the time of recruitment, were free of dementia
and did not have mental or neurological disorders that could be
attributed to the use of substances (such as alcohol) or HIV. We
also excluded men with BMI,18.5 (Figure 1). After recruitment,
participants were followed using the Western Australia Data
Linkage System (WADLS) until they received a diagnosis of
dementia, died or completed follow-up on the 30
th September
2009, whichever came first (see below). The Human Research
Ethics Committee of the University of Western Australia approved
the study protocol and all participants offered written informed
consent. This project was conducted according to the principles of
the Declaration of Helsinki.
Outcomes of interest
Morbidity and mortality data were retrieved from WADLS, one
of the most comprehensive electronic health record systems in the
world [16]. WADLS brings together name-identified records for
all in-patient hospital admissions as well as public sector mental
health services (in-patient, out-patient and community mental
health services), and includes all morbidity and mortality data of
Western Australia coded according to the International Classifi-
cation of diseases tenth revision (ICD-10) and, for events that
occurred before 1996, the ICD-9.
The diagnosis of dementia was the primary endpoint of interest
of the study, and was defined according to the following ICD-9
and ICD-10 codes: all listed diagnoses (primary and secondary) for
Alzheimer’s dementia 331.0, F00, G30; Vascular dementia 290.4,
F01; fronto-temporal dementia 331.1, F02.0, G31.0; Huntington’s
disease 333.4, G10, F02.2; Parkinson’s dementia or dementia with
Lewy bodies F02.3, 331.82; and non-specific dementia 290.0,
290.1, 290.2, 290.3, 290.8, 290.9, 294.1, 294.8, 331.2, F02.8, F03,
F05.1, G31.1, G31.8, G31.9. To improve case ascertainment, the
text terms of the above conditions were searched for in the
morbidity and mortality data systems, along with the following
alternative medical terms: multi-infarct dementia, arteriosclerotic
dementia, fronto-temporal lobe dementia, primary progressive
dementia, corticobasal dementia, and Pick’s dementia. As the
accuracy of specific diagnostic causes of dementia in WADLS is
uncertain, we opted to group all entries under the general heading
of ‘dementia’.
Adiposity measures
We used standard procedures to measure weight (to 0.2 Kg) and
height (to 0.5 cm) of all participants. We calculated the BMI in kg/
m
2 and classified participants as normal weight (18.5#BMI,25),
overweight (25#BMI,30) and obese (BMI$30). We used a steel
measuring tape to determine the WC in centimeters, with
measurements taken halfway between the lower border of the
ribs and the iliac crest in a horizontal plane (to 0.5 cm). A similar
procedure was used to measure hip circumference, with
measurements taken at the widest point around the left and right
greater trochanters. Men were wearing light clothing at the time of
these measurements, which followed the recommendations of the
World Health Organization [17]. We classified men with
94 cm#WC,102 cm as having mild central obesity, and those
with WC$102 cm as having marked central obesity [18].
Similarly, we considered that a WHR$0.9 indicated the presence
of obesity [19].
Other measures
We used a self-rating questionnaire to collect demographic,
lifestyle and clinical information from participants; factors chosen
for analysis were those which have previously been shown in the
literature to be related to cognitive decline in older men. We
calculated the age of participants by subtracting the date of their
birth from the date of their assessment. We grouped men
according to whether they had been born in Australia or overseas,
and recorded men as married if they reported being married or
were living in a de facto relationship. In addition, participants
recorded their highest educational achievement (completed high
school education or greater vs did not complete high school
education). Lifestyle data included smoking history (never smoked,
past smoker, current smoker), alcohol intake reported as standard
drinks in a usual week (none, less than 28 standard drinks per
week, 28 or more standard drinks per week), vigorous exercise of at
least 150 minutes per week (e.g., jogging), and non-vigorous
exercise (e.g., walking); questions regarding eating habits were
Figure 1. Flow of participants from invitation to inclusion in
the study.
doi:10.1371/journal.pone.0017902.g001
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meat and fish, as well as the type of milk they used (e.g.,
condensed, full cream, reduced-fat milk intake only, or a mixture
of these). Information about premorbid clinical diseases and
treatment were self-reported at the time of recruitment into the
study. We asked participants, ‘‘have you ever been told by a doctor
you suffer from or have you ever received treatment for’’ diabetes
(yes/no), dyslipidemia (high cholesterol or triglycerides) (yes/no),
hypertension (yes/no) or coronary heart disease (if the patient
reported having been told by a doctor that they had suffered a
heart attack or that they had angina) (yes/no).
Statistical analysis
We used Cox proportional hazards regression models to
determine the univariate association between measured demo-
graphic, lifestyle and clinical variables with incident dementia.
Survival time was calculated from the date of entry into the study
to the date of first recorded diagnosis of dementia, date of death,
or the end of follow-up (September 30, 2009), whichever came
first. We then investigated the association between markers of
adiposity (BMI, WC, WHR) and incident dementia using, again,
Cox proportional hazard models, and later adjusted those analyses
for possible confounding factors identified in our initial univariate
analysis (p,0.15), as described above. The cumulative hazard of
dementia over follow-up was determined and presented graphi-
cally according to categories for each adiposity marker. We also
investigated the association between dementia and each adiposity
marker by using a restricted cubic spline with 3 knots (i.e., a
function that produces a smooth curve fitted statistically through
three given data points, allowing more flexibility in the regression
model and the investigation of non-linear associations [20]) and
modeling each adiposity marker as a continuous variable; results
from these analyses are shown graphically. Finally, to examine the
robustness of our results, we re-ran all analyses after excluding
men with a survival time of less than 2 years, either because they
developed dementia or died during the first two years of follow-up.
The annual rate of dementia according to the relevant exposures
was estimated using the Stata command strate. Ninety-five percent
confidence intervals (95%CI) were estimated for the HR and rates.
Alpha was set at 5% and all probability tests reported are two-
tailed. We used Stata version 11.1 (StataCorp, College Station,
Texas) for data management and analysis.
Results
Twelve thousand and forty-seven men were included in the
study. Their age ranged from 65 to 84 years at the time of entry
(mean6SD=72.164.4) and 1,271 developed dementia during the
9.763.5 (range: 0.02 to 13.4) years of follow-up; those with
dementia had a mean time in the study of 7.163.0 years, and
Table 1. Demographic, lifestyle and past medical characteristics of participants at time of entry into the study and according to
dementia outcome.
NO DEMENTIA DEMENTIA
N=10,776 N=1,271
BASELINE CHARACTERISTIC N (%) N (%) HR (95%CI)
Age (years) 65–69 4362 (40.5) 249 (19.6) 1 (reference)
70–74 3802 (35.3) 409 (32.2) 2.02 (1.73–2.36)
75–79 2074 (19.2) 444 (34.9) 4.48 (3.84–5.24)
$80 538 (5.0) 169 (13.3) 7.59 (6.24–9.24)
Migrated 4862 (45.1) 552 (43.4) 0.94 (0.84–1.05)
Married 8816 (81.8) 977 (76.9) 0.68 (0.60–0.78)
Completed high school 4373 (40.6) 465 (36.6) 0.81 (0.72–0.91)
Smoking Never 3147 (29.2) 382 (30.1) 1 (reference)
Past 6455 (59.9) 756 (59.5) 1.05 (0.93–1.19)
Current 1169 (10.8) 133 (10.5) 1.12 (0.92–1.37)
Alcohol use (SD) None/sporadic 1704 (15.8) 230 (18.1) 1 (reference)
,28 SD/week 6175 (57.3) 653 (51.4) 0.76 (0.65–0.88)
$28 SD/week 813 (7.5) 96 (7.6) 0.88 (0.69–1.12)
Diet Meat ,2/week 2673 (24.8) 324 (25.5) 1.03 (0.90–1.16)
Fish.2/week 1101 (10.2) 137 (10.8) 1.05 (0.88–1.26)
Reduced-fat milk 3499 (32.5) 376 (29.6) 0.86 (0.76–0.97)
Physical activity No exercise 2670 (24.8) 349 (27.5) 1 (reference)
Non vigorous 5324 (49.4) 673 (53.0) 0.90 (0.79–1.02)
Vigorous 1002 (9.3) 112 (8.8) 0.73 (0.59–0.90)
Hypertension 4513 (41.9) 547 (43.0) 1.12 (1.00–1.25)
Diabetes 1216 (11.3) 187 (14.7) 1.51 (1.29–1.76)
Dyslipidaemia 3327 (30.9) 305 (24.0) 1.45 (1.27–1.65)
Coronary heart disease 2669 (24.8) 361 (28.4) 1.36 (1.20–1.53)
HR=hazard ratio; 95%CI=95% confidence interval of the hazard ratio; SD=standard drinks.
doi:10.1371/journal.pone.0017902.t001
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because follow-up was discontinued once the diagnosis of dementia
was established). The average annual rate of dementia in this cohort
was 10.9% (95%CI=10.3–11.5).
Table 1 shows the distribution of demographic, lifestyle and
clinical variables amongst study participants. Univariate Cox
regression showed that the hazard of dementia increased with age,
but was lower amongst those who were married or had completed
high school. Moderate alcohol use was associated with lower
hazard of dementia compared with no alcohol use, as was the
consumption of reduced-fat milk and vigorous physical activity.
Men with diabetes, dyslipidemia and coronary heart disease had a
greater hazard of dementia than men without these conditions.
Measures of adiposity and dementia risk
Table 2 summarizes the association between measures of
adiposity and incident dementia. Overweight men had lower
dementia hazard than men with normal BMI. Similarly, men with
WHR$0.9 had lower hazard of dementia than men with
WHR,0.9. We then investigated if adiposity measures interacted
with age to mediate the hazard of dementia amongst participants:
the interaction terms between age and all adiposity measures were
not significant (p.0.1; data not shown).
Figure 2 shows the cumulative hazard of dementia over time for
BMI (panel A), WC (panel B) and WHR (panel C) groupings.
Cumulative hazard of dementia over the study period was highest
for those with normal BMI compared with men who were
overweight or obese. Similarly, the cumulative hazard of dementia
was higher for those with WHR,0.9 than for men with
WHR.0.9. The cumulative hazard of dementia did not change
substantially with WC measures.
Figure 3 shows the association between BMI (panel A), WC
(panel B) and WHR (panel C) measurements and the hazard of
dementia in older men. A ‘‘J’’ curve association between
measures of adiposity and hazard of dementia was seen, with
the nadir of risk being in the overweight range of BMI, around
100 cm of WC and just under 1 in WHR. The widening
confidence limits of the hazard of dementia associated with the
extremes of adiposity measures makes relative comparisons
within each group difficult.
Sensitivity analysis
We re-ran all analyses after the exclusion of men who developed
dementia (n=68) or died (n=480) during the first 2 years of
follow-up. The results remained unchanged. Men with BMI
between 25.0 and 30 had lower HR of dementia compared with
normal weight men (crude HR=0.78, 95%CI=0.69–0.88;
adjusted HR=0.82, 95%CI=0.70–0.95). The results for men
with BMI$30 remained borderline non-significant (crude
HR=0.80, 95%CI=0.68–0.95; adjusted HR=0.84, 95%CI=
0.69–1.03). There was no obvious association between WC
grouping and dementia hazard (data not shown), but men with
WHR$0.9 continued to have lower HR of dementia than men
with WHR , 0.9 (crude HR=0.84, 95%CI=0.73–0.97; adjusted
HR=0.81, 95%CI=0.68–0.98).
Discussion
The results of our study show that body mass index and waist-
to-hip ratio measurements are associated with incident dementia
risk in community-dwelling older men. We found that overweight
men (25#BMI,30) and those with WHR$0.9 had the lowest
dementia hazard over 10 years of follow-up, which suggests that
guidelines of body composition used in mid-life should not be used
for older men when evaluating their risk of dementia.
Limitations of the study design
HIMS is an observational study and the distribution of
exposures did not occur at random. In addition, our sample
included only men and we are therefore unable to comment on
whether these findings would apply equally to women. We also
acknowledge that differential survival could have biased the results
of the study, as men who were overweight or obese in mid-life
might have died of competing diseases before reaching older age
[21], so that surviving overweight and obese older men might be
unusually healthy compared with their normal weight counter-
parts. We have previously reported that HIMS participants have
lower mortality hazard than men who were invited but chose not
to participate, and men in the general population who were not
invited [22]. This suggests that HIMS participants are healthier
than other men of their age living in the community, so that
Table 2. Association between measures of adiposity and incident dementia.
NO DEMENTIA DEMENTIA
ANNUAL RATE OF
DEMENTIA HAZARD OF DEMENTIA
ADIPOSITY MEASURES N (%) N (%)
per thousand
(95% CI)
crude HR
(95% CI)
adjusted HR
(95% CI)
BODY MASS INDEX
(BMI) kg/m
2
BMI,25 3256 (30.2) 450 (35.4) 12.9 (11.8–14.2)
25#BMI,30 5546 (51.1) 607 (47.8) 10.1 (9.2–10.8) 0.76 (0.67–0.86) 0.82 (0.70–0.95)
BMI$30 1966 (18.2) 214 (16.8) 10.1 (8.8–11.5) 0.77 (0.66–0.91) 0.82 (0.67–1.01)
WAIST CIRCUMFERENCE (WC) WC,94 cm 3481 (32.3) 437 (34.4) 11.6 (10.5–12.7)
94.0#WC,102 cm 3443 (32.0) 422 (33.2) 11.1 (10.1–12.2) 0.96 (0.84–1.10) 1.02 (0.87–1.20)
WC$102 cm 3848 (35.7) 412 (32.4) 10.1 (9.1–11.1) 0.88 (0.77–1.00) 0.88 (0.74–1.04)
WAIST-TO-HIP RATIO (WHR) WHR,0.9 1695 (15.7) 236 (18.6) 12.6 (11.1–14.3)
WHR$0.9 9076 (84.2) 1035 (81.4) 10.6 (9.9–11.2) 0.84 (0.73–0.97) 0.82 (0.69–0.98)
HR= hazard ratio; 95%CI=95% confidence interval of the hazard ratio.
Adjusted HR=hazard ratio adjusted for age, marital status, education, alcohol consumption, fat intake from milk, physical activity, and prevalent diabetes, dyslipidaemia
and coronary heart disease.
doi:10.1371/journal.pone.0017902.t002
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Furthermore, HIMS recruited men who were living independently
in the community, thereby limiting the inclusion of people with
overt dementia in the sample (hence the low prevalence of
dementia in the inception cohort).
Data on prevalent health conditions was obtained by self-report
(i.e., medical conditions present at the time of recruitment), and
the external validity of such data is yet to be established. Another
factor to consider is that the diagnosis of dementia in our study
relied on the use of data from administrative records and less
severe cases of dementia could conceivably not have been
identified. Such a bias would only influence the results of the
study if the distribution of error across the obesity groups was not
random – for example, if normal weight men with dementia were
greater users of health services than their overweight or obese
counterparts. This seems an unlikely explanation for our results, as
overweight and obese people use of health services more
frequently than people with normal weight (i.e., the opportunity
to make the diagnosis of dementia would be greater for overweight
or obese people because they have more frequent contacts with the
health services) [23]. Moreover, the observed prevalence of
dementia in our sample (with 10.3% (1,271/12047) developing
dementia during follow-up) is similar to those reported by others
using different case-ascertainment methodologies [9,13,14].
Another limitation of our study is the uncertain validity of the
specific diagnosis of dementia using record linkage. For this
reason, we did not attempt to investigate the association between
obesity and the varying causes of dementia and limited our
analyses to the syndromal grouping of ‘dementia’. BMI, WC and
WHR measurements were available only at the time of entry into
the study and, consequently, we cannot comment on whether
repetitive measures would have been more informative in
predicting the development of dementia during follow-up.
It is also possible that obesity measures are associated with
differential survival and that this may have confounded their
association with dementia. We attempted to address this issue by
excluding from the analysis men who died during the initial 2
years of follow-up, which did not alter the results of the study.
We could have extended this exclusion to men who died within
the first 5 years of follow-up, but this would have reduced the
power of the study substantially in such an old cohort. In fact,
our group has previously shown that survival amongst these old
men was longest for those in the overweight group [3]. As
overweight men survive longer, they would have greater
Figure 2. Cumulative hazard of dementia over time according to adiposity markers in elderly men. The left, middle and right panels
show the hazard ratio (HR) of dementia over time for body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR) groupings,
respectively.
doi:10.1371/journal.pone.0017902.g002
Figure 3. Average hazard of dementia (blue line) during follow-up according to the body mass index (BMI) (left panel), waist
circumference (WC) (middle panel) and waist-to-hip ratio (WHR) (right panel). The vertical dashed red line represents the reference value
for each indicator: 25 for BMI, 94 cm for WC, and 0.9 for WHR. The dashed blue lines represent the 95% confidence interval of the hazard ratio.
doi:10.1371/journal.pone.0017902.g003
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up, which is exactly the opposite of what we observed (i.e., our
findings seem robust).
There is also some evidence that older people who are
underweight have a higher risk of dementia than those with
normal weight [9,24], but the association between low BMI and
increased dementia risk seems to be due to acute loss rather than
longstanding low body mass [9,24]. Others have reported similar
findings in younger age groups [9,14]. For this reason, men with
BMI in the underweight range were excluded from our analyses
and, despite this conservative approach, we found that low
adiposity in the normal range seems to increase the 10-year risk of
incident dementia in older men. Some authors suggest that rather
than being a risk factor for dementia, low BMI may be a marker of
an underlying dementia process not yet clinically detectable [9,24],
and Atti and colleagues (2008) postulated that the time-dependent
association they observed in their study supported this possibility.
This study attempted to address the issue of reverse causality by
excluding those people with a survival time of less than 2 years
(either because they developed dementia or died), and this did not
alter the results. As previously mentioned, a limitation of the study
was having gathered adiposity measures at only one point, hence
we were unable to monitor any changes in the weight of
participants over time.
This study has strengths that also merit comment. To the best of
our knowledge, this is one of the largest and longest studies of older
men involved in an investigation of adiposity and dementia in later
life. Further, rather than being restricted to BMI like many
previous studies investigating the relationship between adiposity
and dementia, HIMS collected information on three key-markers
of adiposity, two of which are considered good indicators of central
obesity and are more strongly associated with cardiovascular
endpoints than BMI [25,26]. Bias due to attrition is another
important issue to consider in longitudinal studies; however in
HIMS follow-up was assured as outcomes were monitored via the
WADLS and less than 1% of older Western Australians die outside
the state [27]. Moreover, our sensitivity analysis showed that the
results of the study remained consistent after the exclusion of men
who developed dementia or died during the first 2 years of follow-
up. However, we concede that some men may have had incipient
dementia at the time of recruitment that only became clinically
apparent after 2 years, and as a result the possibility of reverse
causality cannot be dismissed entirely.
Interpretation of findings
Our results suggest that measures of adiposity are associated
with incident dementia in later life, with the lowest dementia
hazard falling within the overweight BMI range and WHR$0.9.
The cumulative hazard of dementia was greatest amongst normal
weight men (BMI,25) and those with WHR,0.9. We also found
a J-shaped association between dementia hazard and measures of
adiposity, with nadir in the overweight range, which suggests that
mild to moderate accumulation of adipose tissue reduces the risk of
dementia in older men. These findings have relevance to the
ongoing debate about developing suitable guidelines for adiposity
markers in later life: older men who have a slight increase in
adiposity markers may not be at greater risk of dementia, and
current guidelines for ‘‘healthy’’ adiposity values for BMI, WC and
WHR might require recalibration in older age [3].
Numerous studies have shown that excess abdominal fat
(caused largely by the accumulation of visceral fat) correlates with
an increased risk of adverse health outcomes, such as hyperten-
sion, dyslipidemia and hyperglycemia [28,29], and as a measure
of abdominal visceral fat, WC appears to be a more sensitive
indicator of adverse health outcomes than BMI or WHR
[25,26,30]. One way of explaining these findings is to consider
that BMI and WHR, but not WC, may be indicators of
physiological and nutritional fitness in later life. It is possible, for
example, that changes in the quantity and distribution of adipose
tissue in older age are adaptive and may confer a protective effect
to the brain that minimizes the risk of cognitive decline, and that
the loss of adipose tissue may deprive the aging brain of that
benefit [31]. At this stage such an explanation is highly
speculative, but evidence linking overweight to decreased
mortality in older age suggests that this hypothesis cannot be
simply dismissed [3]. Furthermore, preliminary basic science data
suggests that our findings may be biologically plausible. For
example, leptin, which is produced in the adipose tissue, is
thought to be involved in brain development, learning and
memory [32]. Direct administration of leptin into the hippocam-
pus in mice improves memory processing and increases the
expression of NMDA receptors, enhances learning and memory
performance, and contributes to regulate hippocampal synaptic
plasticity [33]. Interestingly, the serum concentration of leptin
shows an inverse relationship with the risk of Alzheimer’s disease
in later life [34,35].
Nonetheless, our results are also consistent with those of recent
prospective studies indicating that whilst mid-life obesity is a risk
factor for dementia, overweight and mild obesity in later life are
not [9,13,14]. Nonetheless, disparate results have also been
reported, particularly for older women [12,36], and reasons for
these conflicting outcomes have been discussed at length by others
[37].
In conclusion, BMI and WHR measurements have a J-shaped
association with dementia risk in this Australian cohort of older
men, with the lowest risk falling within the overweight range. If
replicated, these findings would have implications for public health
recommendations on adiposity measures and for research into the
physiological mechanisms linking adiposity to dementia in later
life.
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